Company news
Ventripoint Diagnostics Ltd. news in 2021
Ventripoint Diagnostics Ltd.'s news releases, calls and decks from 2021, newest first.
Ventripoint Successfully Renews QMS Certification
December 29, 2021
Ventripoint Expands United Kingdom Marketing with New Distribution Partner CardioLogic
December 21, 2021
Ventripoint Appoints Randy AuCoin to Board of Directors
December 20, 2021
Ventripoint Receives Additional Funding to Develop Next Generation of the VMS+, Whole-Heart Analysis System
December 6, 2021
Ventripoint Applauds the US Government for Establishing an Additional Payment to Doctors for Analyzing 3D Heart Scans
November 29, 2021
Ventripoint Selected by Life Sciences Ontario as 2021 Success Story
November 24, 2021
Ventripoint Provides Corporate Update on Market Adoption of VMS+ Whole-heart Analysis System
November 22, 2021
Ventripoint Passes Audit of Manufacturing Facility for Canadian and US Markets
November 9, 2021
Ventripoint Appoints Fiona Fitzgerald to the Board of Directors
October 25, 2021
Ventripoint Installs VMS+ 3.0 Unit at East Midlands Congenital Heart Centre
October 21, 2021
Ventripoint Diagnostics Ltd. Announces Closing of Upsized Bought Deal Offering of Units
October 20, 2021
Ventripoint Diagnostics Ltd. Announces Filing of Second Amended and Restated MD&A
October 13, 2021
Ventripoint Diagnostics Ltd. Announces Filing of Amended and Restated Interim Financial Statements and MD&A
October 1, 2021
Ventripoint Diagnostics Ltd. Announces Upsize to Previously Announced Bought Deal Offering of Units to $7 Millon
September 28, 2021
Ventripoint Diagnostics Ltd. Announces $5 Million Bought Deal Offering of Units
September 27, 2021
Ventripoint Issues Option Grants to Consultant
September 17, 2021
Ventripoint Provides Update on Clinical Studies
September 15, 2021
Ventripoint Provides Update on Growth Initiatives and Sales
September 14, 2021
Ventripoint Issues Option Grants to Consultants and Reports Options Exercise
September 7, 2021
Ventripoint Reports Second Quarter 2021 Financial Statements and MD&A
September 3, 2021
Ventripoint Announces Patent Application for Improved Heart Analysis
August 9, 2021
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
July 5, 2021
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
July 2, 2021
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
May 21, 2021
Ventripoint update on its Financial Status and on Warrant and Option Exercises
May 6, 2021
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
May 4, 2021
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
April 27, 2021
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
April 20, 2021
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
April 19, 2021
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
April 15, 2021
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
April 13, 2021
Ventripoint JV Begins Process to have Heart Analysis System Certified for use in COVID Patients in China
March 16, 2021
Ventripoint Passes Regulatory Inspection of Manufacturing Facility and Audit of Quality Assurance System
March 9, 2021
Ventripoint Announces Extension Warrants from March 23, 2021 to May 23, 2021
March 3, 2021
Ventripoint Diagnostics Receives Additional Innovation Assistance Program Funding and Updates Warrant Exercises
March 3, 2021
Ventripoint JV Begins Training Chinese Cardiologists in Heart Analysis System and Achieves Milestone of First Commercial Sales
March 2, 2021
Correction - Ventripoint Diagnostics Issues Shares in Final Payment of Debenture Interest
February 24, 2021
Ventripoint Heart Analysis System to be used at the Stollery Children's Hospital to Study Atrial Dysfunction in Children
February 23, 2021
Ventripoint Advances Sales, Marketing, and Distribution Partnership in the Largest Market in World for Heart Disease: China
February 16, 2021
Ventripoint Diagnostics Issues Shares in Final Payment of Debenture Interest
February 10, 2021
Ventripoint Diagnostics Upgrades Investor Relations Webpage
February 9, 2021
Ventripoint Issues Option Grants
February 8, 2021
Correction: Ventripoint Accelerated Expiry Date of Warrants
February 8, 2021
Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services
February 5, 2021
Ventripoint Announces Complete Conversion of Secured Convertible Debentures, Exercise of Warrants and Accelerated Expiry Date of Warrants
February 3, 2021
Ventripoint Issues Option Grants and Exercises
January 27, 2021
Ventripoint Diagnostics Issues Shares in Payment of Consulting Fees
January 18, 2021
Ventripoint Announces Filing of Articles of Amendment
January 13, 2021
Ventripoint Expands to Address the Needs of Companion Animals
January 11, 2021
Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System
January 4, 2021